Price T Rowe Associates Inc Ocular Therapeutix, Inc Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,110,454 shares of OCUL stock, worth $9.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,110,454

Previous 662,672 67.57%

Holding current value

$9.64 Million

Previous $6.03 Million 25.97%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $1.88 Million - $3.89 Million	447,782 Added 67.57%	1,110,454 $7.6 Million
Q1 2024 May 15, 2024	BUY	$3.85 - $10.93 $2.35 Million - $6.66 Million	609,328 Added 1142.26%	662,672 $6.03 Million
Q4 2023 Feb 14, 2024	BUY	$2.08 - $4.52 $26,746 - $58,122	12,859 Added 31.76%	53,344 $238,000
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $5,796 - $9,303	1,846 Added 4.78%	40,485 $128,000
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $1,582 - $2,628	344 Added 0.9%	38,639 $200,000
Q1 2023 May 15, 2023	SELL	$2.79 - $6.27 $9,949 - $22,358	-3,566 Reduced 8.52%	38,295 $202,000
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $28,636 - $48,386	10,972 Added 35.52%	41,861 $118,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $20,372 - $32,376	4,981 Added 19.23%	30,889 $129,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $18,562 - $32,191	6,167 Added 31.24%	25,908 $104,000
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $31,303 - $47,635	6,481 Added 48.88%	19,741 $98,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $131,208 - $257,091	-21,300 Reduced 61.63%	13,260 $92,000
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $969 - $1,434	-100 Reduced 0.29%	34,560 $346,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $23,623 - $33,702	1,759 Added 5.35%	34,660 $491,000
Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $110,312 - $154,173	6,973 Added 26.89%	32,901 $540,000
Q4 2020 Feb 16, 2021	BUY	$7.91 - $22.95 $205,090 - $595,047	25,928 New	25,928 $537,000

Others Institutions Holding OCUL

# of Institutions

151

Shares Held

136M

Call Options Held

86.4K

Put Options Held

263K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Ocular Therapeutix, Inc Transaction History